Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 15Lymphoma, Large B-Cell, Diffuse 9Lymphoma 9Burkitt Lymphoma 5Lymphoma, Non-Hodgkin 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Sezary Syndrome 2Recurrence 2Primary Myelofibrosis 2Myeloproliferative Disorders 2Mycosis Fungoides 2Multiple Myeloma 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Hairy Cell 2Hodgkin Disease 2Graft vs Host Disease 2Blast Crisis 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1

Interventions

Prednisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Exanthema × Prednisone × Sarcoma × Clear all
NCT03440515 2020-01-07

Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal Tumor

Asan Medical Center

Phase 2 Completed
29 enrolled
GastrointestinalSarcoma

Exanthema, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡